Previous 10 | Next 10 |
Magellan Health Services (NASDAQ: MGLN ): Q4 EPS of -$0.77 may not be comparable to consensus of $1.08. More news on: Magellan Health Services, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Magellan Health, Inc. (NASDAQ: MGLN) today announced financial results for the fourth quarter and full year ended December 31, 2018, as summarized below: Highlights Include: Net revenue for the year ended December 31, 2018 increased to $7.3 billion from 2017. Net income for...
AAON , ABB , ACIW , AKRX , AMCX , AMRX , BCPC , BID , BMCH , BPMP , BUD , CARS , CM , CMD , CNP , CROX , CWEN , CWT , DAVA , DEA , EGRX , ENDP , EXLS , FOLD , FRO , FSS , GOLF , GTN , GTT , HMHC , HRI , IBP , ICPT , IRDM , JCP , JD , KDP , LAUR , LKQ ,...
Magellan Health Services (NASDAQ: MGLN ) is scheduled to announce Q4 earnings results on Thursday, February 28th, before market open. The consensus EPS Estimate is $1.08 (-57.6% Y/Y) and the consensus Revenue Estimate is $1.9B (+12.4% Y/Y). Over the last 2 years, MGLN has beaten EPS e...
Magellan Health, Inc. (NASDAQ: MGLN) today acknowledged that Starboard Value LP (“Starboard”) has provided notice of its intent to nominate six candidates to stand for election to the Board of Directors at the Company’s 2019 Annual Meeting of Shareholders. Starboard st...
Starboard Value LP, one of the largest shareholders of Magellan Health (NASDAQ: MGLN ) will nominate a full slate of highly qualified candidates for election to the Board of Directors at the Company's 2019 Annual Meeting of Shareholders. More news on: Magellan Health Services, Inc., Heal...
Alexion Pharmaceuticals (NASDAQ: ALXN ) initiated with Neutral rating and $135 (6% upside) price target at Guggenheim. More news on: Alexion Pharmaceuticals, Inc., Dermira, Exelixis, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
NEW YORK , Feb. 22, 2019 /PRNewswire/ -- Starboard Value LP (together with its affiliates, "Starboard"), one of the largest shareholders of Magellan Health, Inc. ("Magellan" or the "Company")(NASDAQ: MGLN), with an ownership interest of approximately 9.8% of the Company's outstanding shar...
Ninth annual report features a comprehensive view of medical pharmacy trends in claims data, including all major lines of business Magellan Rx Management, the pharmacy benefit management (PBM) division of Magellan Health, Inc. (NASDAQ: MGLN) released its ninth annual Medical Phar...
Magellan Health, Inc . (NASDAQ: MGLN) today announced that it will report its earnings for the fourth quarter and full year ended on December 31, 2018 at approximately 6:30 a.m. Eastern on Thursday, February 28, 2019. At 8:30 a.m. Eastern on the same day, Magellan's...
News, Short Squeeze, Breakout and More Instantly...
Consultation and resources available at no cost to local community Magellan Health, Inc. today announced that it has opened a complimentary 24-hour crisis line for individuals impacted by the high school shooting that occurred in St. Louis, Missouri on Monday. The ...
Solution is powered by DUOS and will help older adults stay connected and live their lives with greater independence and self-sufficiency Magellan Healthcare, Inc. , the behavioral and specialty healthcare segment of Magellan Health, Inc. , today announced the launch...
Consultation and resources available at no cost to local community Magellan Health, Inc. today announced that it has opened a complimentary 24-hour crisis line for individuals impacted by the aftermath of Hurricane Ian. The toll-free number to access free, confiden...